The most recent listing of current clinical trials for head and neck cancer — including head and neck and thyroid — appears below. Should you be interested in learning more about any of these clinical trials, please use our Contact Us form.
Site: Head and Neck
(Includes Head and Neck and Thyroid)
| Protocol ID |
|
Title |
|
| E1302 |
|
Phase III Randomized, Placebo Controlled, Trial of Docetaxel v. Docetaxel plus ZD1839 (Iressa, Gefitinib) in Performance Status 2 or Previously Treated Patients with Recurrent or Metastatic Head and Neck Cancer
Keywords: performance status 2 or previously treated patients with recurrent or metastatic head and neck cancer |
|
| RTOG 0514 |
|
Establishment of A Head and Neck Cancer Tissue/ Specimen Bank
Keywords: head and neck cancer |
|
| In-House |
|
A Pilot Study to Evaluate the Impact of Computed Tomograph Perfusion on the Gross Target Volume Definition in Patients with Head and Neck Carcinoma
Keywords: head and neck cancer |
|
| RTOG 0522 |
|
A Randomized Phase III Trial of Concurrent Accelerated Radiation and Cisplatin versus Concurrent Accelerated Radiation, Cisplatin, and Cetuximab (C225) (followed by surgery for selected patients) for Stage III and IV Head and Neck Carcinomas
Keywords: Stage III and IV head and neck cancer |
|
| RTOG 0615 |
|
A Phase II Study of Concurrent Chemoradiotherapy Using Three-Dimensional Conformal Radiotherapy (3D-CRT) or Intensity- Modulated Radiation Therapy (IMRT) + Bevacizumab (BV) for Locally or Regionally Advanced Nasopharyngeal Cancer
Keywords: Locally or Regionally Advanced Nasopharyngeal Cancer |
|
| Industry-H&N |
|
Prospective, Longitudinal, Multi-Center, Descriptive Registry of Patients Receiving Therapy other than Surgical Resection Alone for Newly Diagnosed Head and Neck Carcinoma
Keywords: newly diagnosed head and neck carcinoma |
|
| Northwestern Oral Leukoplakia |
|
A Phase I Trial of ALA for Treatment of Oral Leukoplakia
Keywords: Oral Leukoplakia |
|
| In-House |
|
Biologic Correlates of Oral Premalignancy
Keywords: Oral Premalignancy |
|
| U of C 14696A |
|
Phase II Trial of Sunitinib (SU11248) in Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers and Medullary Thyroid Cancers
Keywords: unresectable differentiated thyroid cancers and medullary thyroid cancers |